Abbott India informs about statement of investor complaints

06 Apr 2017 Evaluate

Abbott India has informed about Statement of Investor Complaints under Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the fourth quarter ended March 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Abbott India Share Price

28623.25 -446.60 (-1.54%)
01-Jan-2026 13:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1250.75
Cipla 1499.50
Zydus Lifesciences 913.35
Lupin 2099.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×